<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02040714</url>
  </required_header>
  <id_info>
    <org_study_id>IPSG 001</org_study_id>
    <nct_id>NCT02040714</nct_id>
  </id_info>
  <brief_title>Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease</brief_title>
  <acronym>IPSG1</acronym>
  <official_title>Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Texas Scottish Rite Hospital for Children</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Alberta Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Alfred I. duPont Hospital for Children</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Le Bonheur Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital Colorado</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital Los Angeles</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Healthcare of Atlanta</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital of Philadelphia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital Medical Center, Cincinnati</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Connecticut Children's Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gillette Children's Specialty Healthcare</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Boston Children’s Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kaiser Permanente</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kasturba Medical College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical Universtity of Lodz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Montefiore Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nationwide Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>New York University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>OrthoCarolina Research Institute, Inc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Seoul National University Childrens Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shriners Hospitals for Children</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Southampton NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Texas Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Phoenix Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sheffield Children's NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Royal Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Texas Scottish Rite Hospital for Children</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Legg-Calvé-Perthes disease is a childhood hip disorder which is common enough to be a
      significant public health problem (affects 1 in 740 boys between ages 0—14), but uncommon
      enough to have a sufficient number of patients from a single institution to perform a
      definitive prospective study comparing the results of current treatments. The present study
      will establish a database of prospectively identified patients with Legg-Calvé-Perthes (LCP)
      Disease and collect information regarding their presentation, treatment, and outcomes in the
      course of receiving currently available treatments.

      This study seeks to compare the outcomes of current treatments in the management of different
      age groups (ages 1-6, 6—8, 8—11, &gt;11) of patients with Perthes disease at two- and five-year
      followup and at skeletal maturity. For each age group, two to three common treatment regimens
      currently used by practicing pediatric orthopaedic surgeons will be compared. The
      intervention a patient receives is determined through physician preference. Physicians pick
      an intervention for each age group and treat each patient with the same intervention.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Approximately 50 pediatric orthopaedic surgeons from pediatric centers in the US and other
      countries have agreed to participate in this database as members of the International Perthes
      Study Group (IPSG). TSRH will be the lead center. Those who agree to participate will seek
      IRB approval from their own institutions. Data will be collected prospectively and entered
      into REDCap (Research Electronic Data Capture), a browser-based research database. Patient
      Reported Outcomes Measurement Information System (PROMIS) questionnaires will be completed
      via an online testing system, the NIH funded Assessment Center.

      1-6 Cohort: For the 1-6 age patient group, patients presenting in an early stage of the
      disease (stage I or IIa), the surgeons who treat patients with one of the following treatment
      regimens currently used in practice will be asked to participate in the study.

        1. Non-operative management (i.e., no osteotomy but can include soft tissue release)

        2. Operative containment treatment (femoral or pelvic osteotomy or Shelf acetabuloplasty).

      6-8 Cohort: For the 6—8 age patient group, patients presenting in an early stage of the
      disease (stage I or IIa), the surgeons who treat their patients with one of the following
      three treatment regimens currently used in practice will be asked to participate in the study
      2-4.

        1. Non-operative management (i.e., no osteotomy but can include soft tissue release);

        2. Operative containment treatment (femoral or pelvic osteotomy or Shelf acetabuloplasty).

      8-11 Cohort:

      For the 8—11 patient age group, patients presenting in an early stage of the disease (stage I
      or IIa), the surgeons who treat their patients with one of the following treatment regiments
      currently used in practice will be asked to participate in the study:

        1. Non-operative management (i.e., no osteotomy);

        2. Operative containment treatment (femoral or pelvic osteotomy or Shelf acetabuloplasty)
           followed by 6 weeks of postoperative non-weight bearing; and,

        3. Operative containment treatment (femoral or pelvic osteotomy or Shelf acetabuloplasty)
           followed by 6 months of postoperative non-weight bearing.

      &gt;11 Cohort Registry:

      For the &gt;11 patient age group, patients presenting in an early stage of the disease (stage I
      or IIa) we will collect prospective data from surgeons who are currently treating their
      patients with one of the following alternative treatment regimens 5,6:

        1. Non-operative management (i.e. no osteotomy);

        2. Core decompression or multiple epiphyseal drilling of the necrotic femoral head with
           post-operative non-weight bearing; or,

        3. Core decompression or multiple epiphyseal drilling of the necrotic femoral head with
           application of hinged hip distractor.

      Patients who present to an IPSG member or their group during the late stages of the disease
      (stage IIb or stage III) will also be arranged into four separate age cohorts, identical to
      the list above. We will collect prospective data from surgeons who are currently treating
      these patients with operative or non-operative treatment regimens.

      Regardless of the patient's stage at enrollment, the patient's age at diagnosis or assigned
      cohort, the following data will be collected: information regarding patient characteristics
      at presentation, physical exam findings, responses to Perthes patient and/or outcomes
      questionnaires, and results of radiographic and MR imaging. Participants will be assigned a
      unique study number. A secure web application, REDCap, will be used to capture and store
      research information including de-identified radiographic and MR images, clinical
      information, and Perthes patient and/or outcomes questionnaire responses.

      All patients willing to complete the PROMIS questionnaires will do so regardless of group,
      treatment, or stage of the disease. The administration of the instrument is facilitated by
      the use of an online testing platform, the NIH-funded Assessment Center. Data will be
      transmitted and stored on a secure and dedicated server for the purpose of this study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">September 2032</completion_date>
  <primary_completion_date type="Anticipated">September 2032</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sphericity deviation score of the femoral head</measure>
    <time_frame>5 years post intervention</time_frame>
    <description>The primary outcome for each age group will be a quantitative estimate of the sphericity of the femoral head as a measure of femoral head deformity. A more deformed head will be less spherical. Greater deformity leads to an increased risk of arthritis early in life.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Perfusion percentage</measure>
    <time_frame>Just after diagnosis of Perthes disease</time_frame>
    <description>The perfusion percentage is a measure of the amount of blood flow in the femoral head relative to the volume of the whole head. This measure is calculated from the perfusion MRI images that are collected just prior to the application of the intervention.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Stulberg classification</measure>
    <time_frame>at 2 years and 5 years post intervention</time_frame>
    <description>The Stulberg classification is a categorical system used to describe the shape of the femoral head that is traditionally used to evaluate outcomes and arthritis risk for patients with Perthes disease.</description>
  </other_outcome>
  <number_of_groups>14</number_of_groups>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Legg Calve Perthes Disease</condition>
  <arm_group>
    <arm_group_label>Nonoperative management between ages 6-8</arm_group_label>
    <description>The choice of non-osteotomy management without containment or surgical containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Operative containment between age 6-8 in early stage</arm_group_label>
    <description>Operative containment treatment (femoral or pelvic osteotomy or Shelf acetabuloplasty) rendered in the early stage of the disease process (stage I)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Operative containment between age 6-8 in the late stages</arm_group_label>
    <description>This arm examines operative containment treatment (femoral or pelvic osteotomy or Shelf acetabuloplasty) rendered in the later stage of the disease process (stage II)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nonoperative management between age 8-11</arm_group_label>
    <description>Patients who do not undergo some form of containment surgery because of medical, social, or other reasons will receive no surgical treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Operative containment with short-term non-weightbearing</arm_group_label>
    <description>As per the current standard practice for patients between age 8-11 in developed countries, all patients will undergo some form of containment surgery (pelvic or femoral osteotomy) in order to better &quot;contain&quot; the femoral head underneath the acetabulum. Post-operative treatment will include 6 weeks of non-weight bearing on the operated leg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Operative containment with prolonged non-weightbearing</arm_group_label>
    <description>As per the current standard practice for patients between age 8-11, all patients will undergo some form of containment surgery (pelvic or femoral osteotomy) in order to better &quot;contain&quot; the femoral head underneath the acetabulum. Post-operative treatment will include 6 months of non-weight bearing on the operated leg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Multiple epiphyseal drilling for patients over age 11</arm_group_label>
    <description>Patients will receive Multiple drilling and be non weight bearing for 6 months according to the treating physician's preference</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Multiple epiphyseal drilling and arthrodiastasis</arm_group_label>
    <description>Patients will undergo multiple epiphyseal drilling with application of fixator for 3-4 months followed by 8-12 weeks of non-weight bearing after fixator removal.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-surgical management in over 11 age group</arm_group_label>
    <description>Patients will be non-weight bearing and receive physical therapy according to the physician preferences.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-surgical management in 1-6 age group</arm_group_label>
    <description>The choice of non-osteotomy management without containment or surgical containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Surgical management in 1-6 age group</arm_group_label>
    <description>The choice of osteotomy management with containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Late Stage Bracing group</arm_group_label>
    <description>Patients presenting with &lt;= 20 degrees of abduction on a maximum abduction x-ray treated with bracing who also present in the late stages of the disease (Waldenstrom Stage IIb or IIIa).The choice of management with or without containment or surgical containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Late Stage Symptomatic treatment group</arm_group_label>
    <description>Patients presenting in the late stages of the disease (defined as Waldenstrom stage IIb or IIIa) who are treated symptomatically. The choice of management with or without containment or surgical containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Late Stage Surgical Containment group</arm_group_label>
    <description>Patients presenting in the late stages of the disease (defined as Waldenstrom stage IIb or IIIa) who are treated with surgical containment. The choice of management with or without containment or surgical containment would be solely governed by the current practice of the participating surgeons (i.e. the current practice of the individual surgeon would be followed within the broad framework of the study).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>osteotomy</intervention_name>
    <description>Surgical procedures that improve femoral head containment</description>
    <arm_group_label>Operative containment between age 6-8 in early stage</arm_group_label>
    <arm_group_label>Operative containment between age 6-8 in the late stages</arm_group_label>
    <arm_group_label>Operative containment with short-term non-weightbearing</arm_group_label>
    <arm_group_label>Operative containment with prolonged non-weightbearing</arm_group_label>
    <arm_group_label>Surgical management in 1-6 age group</arm_group_label>
    <arm_group_label>Late Stage Surgical Containment group</arm_group_label>
    <other_name>Femoral osteotomy</other_name>
    <other_name>Shelf osteotomy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>multiple epiphyseal drilling</intervention_name>
    <description>Multiple epiphyseal drilling is a procedure that creates small holes in the femoral head growth plate to increase blood flow into the femoral head.</description>
    <arm_group_label>Multiple epiphyseal drilling for patients over age 11</arm_group_label>
    <arm_group_label>Multiple epiphyseal drilling and arthrodiastasis</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participants with a recent diagnosis of Perthes disease that are being followed by a
        participating orthopedic surgeon. Participants are invited to participate during a visit to
        their treating hospital.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed with Legg-Calvé-Perthes disease

          -  Between age 1-18

          -  Patients with possible secondary femoral osteonecrosis if over the age of 11 due to
             trauma or corticosteroid therapy are also eligible.

        Exclusion Criteria:

          -  Patients with previous surgical treatment on the affected hip if not in the &gt;11 age
             group
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Harry KW Kim, MD, MS</last_name>
    <role>Study Chair</role>
    <affiliation>Texas Scottish Rite Hospital for Children</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Harry K Kim, PhD</last_name>
    <phone>(214) 559-7620</phone>
    <email>harry.kim@tsrh.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Molly McGuire, MPH</last_name>
    <phone>(214) 559-5112</phone>
    <email>molly.mcguire@tsrh.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shawn Gilbert, MD</last_name>
      <phone>205-975-7499</phone>
      <email>srgilbert@uabmc.edu</email>
    </contact>
    <investigator>
      <last_name>Shawn Gilbert, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Phoenix Children's Hospital</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Judson Karlen, MD</last_name>
      <phone>602-546-1000</phone>
      <phone_ext>85927</phone_ext>
      <email>jkarlen@phoenixchildrens.com</email>
    </contact>
    <investigator>
      <last_name>Judson Karlen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Hospital</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Kessler, MD</last_name>
      <phone>323-783-9313</phone>
      <email>Jeffrey.I.Kessler@kp.org</email>
    </contact>
    <contact_backup>
      <last_name>Vedant Kulkarni, MD</last_name>
      <email>vedantkulkarni@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Jeffrey Kessler, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vedant Kulkarni, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Choi, MD</last_name>
      <email>pchoi@chla.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Paul Choi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eduardo Novais, MD</last_name>
      <phone>720-777-6600</phone>
      <email>Eduardo.Novais@childrenscolorado.org</email>
    </contact>
    <investigator>
      <last_name>Eduardo Novais, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Connecticut Children's Medical Center</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philip Mack, MD</last_name>
      <phone>660-545-8643</phone>
      <email>pwmack60@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Philip Mack, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nemours/Alfred I. duPont Hospital for Children</name>
      <address>
        <city>Wilmington</city>
        <state>Delaware</state>
        <zip>19803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mihir Thacker, MS, DNB, FCPS (Ortho)</last_name>
      <phone>302-651-4200</phone>
      <email>mthacker@nemours.org</email>
    </contact>
    <investigator>
      <last_name>Mihir Thacker, MS, DNB, FCPS (Ortho)</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's National Medical Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin Martin, MD</last_name>
      <phone>202-476-4063</phone>
      <email>bdmartin@childrensnational.org</email>
    </contact>
    <investigator>
      <last_name>Benjamin Martin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Orthopaedics of Atlanta</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tim Schrader, MD</last_name>
      <phone>678-686-6816</phone>
      <email>tschrad@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Tim Schrader, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lurie Children's Hospital of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph Janicki, MD</last_name>
      <email>jjanicki@luriechildrens.org</email>
    </contact>
    <investigator>
      <last_name>Joseph Janicki, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21218</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Boston</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115-5724</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Young-Jo Kim, MD, MS, FRCSC</last_name>
      <phone>617-355-7497</phone>
      <email>Young-jo.Kim@childrens.harvard.edu</email>
    </contact>
    <contact_backup>
      <last_name>Benjamin Shore, MD, FRCSC</last_name>
      <phone>617-355-6021</phone>
      <email>Benjamin.Shore@childrens.harvard.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Young-Jo Kim, MD, MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benjamin Shore, MD, FRCSC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Noelle Larson, MD</last_name>
      <phone>507-284-2995</phone>
      <email>Larson.Noelle@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Noelle Larson, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gillette Children's Specialty Healthcare</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Laine, MD</last_name>
      <phone>651-578-5061</phone>
      <email>Jennifer.Laine@Gillettechildrens.com</email>
    </contact>
    <investigator>
      <last_name>Jennifer Laine, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stephen Sundberg, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NYU Hospital for Joint Diseases</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>New York Presbyterian Hospital (Columbia Campus)</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joshua Hyman, MD</last_name>
      <phone>212-305-5475</phone>
      <email>jh736@columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Joshua Hyman, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Montefiore Greene Medical Arts Pavilion</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Fornari, MD</last_name>
      <phone>718-920-2060</phone>
      <email>efornari@montefiore.org</email>
    </contact>
    <investigator>
      <last_name>Eric Fornari, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>OrthoCarolina</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Virginia Casey, MD</last_name>
      <phone>704-323-2543</phone>
      <email>Virginia.Casey@orthocarolina.com</email>
    </contact>
    <investigator>
      <last_name>Virginia Casey, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charles Mehlman, DO, MPH</last_name>
      <phone>513-636-4087</phone>
      <email>Charles.Mehlman@cchmc.org</email>
    </contact>
    <contact_backup>
      <last_name>Junichi Tamai, MD</last_name>
      <phone>513-636-4785</phone>
      <email>junichi.tamai@cchmc.org</email>
    </contact_backup>
    <investigator>
      <last_name>Charles Mehlman, DO, MPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Junichi Tamai, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nationwide Children's Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kevin Klingele, MD</last_name>
      <phone>614-722-3390</phone>
      <email>Kevin.Klingele@nationwidechildrens.org</email>
    </contact>
    <investigator>
      <last_name>Kevin Klingele, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wudbhav Sankar, MD</last_name>
      <phone>215-590-1527</phone>
      <email>sankarw@email.chop.edu</email>
    </contact>
    <investigator>
      <last_name>Wudbhav Sankar, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Tennessee-Campbell Clinic</name>
      <address>
        <city>Germantown</city>
        <state>Tennessee</state>
        <zip>38138</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Derek M Kelly, MD</last_name>
      <phone>901-759-5552</phone>
      <email>dkelly@campbellclinic.com</email>
    </contact>
    <investigator>
      <last_name>Derek M Kelly, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Scottish Rite Hospital for Children</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Molly McGuire, MPH</last_name>
      <phone>214-559-5112</phone>
      <email>molly.mcguire@tsrh.org</email>
    </contact>
    <contact_backup>
      <last_name>Terri Beckwith, MPH</last_name>
      <phone>214-559-8481</phone>
      <email>terri.beckwith@tsrh.org</email>
    </contact_backup>
    <investigator>
      <last_name>Harry Kim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tony Herring, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Children's Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Scott Rosenfeld, MD</last_name>
      <phone>832-822-3109</phone>
      <email>sbrosenf@texaschildrens.org</email>
    </contact>
    <investigator>
      <last_name>Scott Rosenfeld, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shriners Hospital for Children, Salt Lake City</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Seattle Children's Hospital</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Klane White, MD, MSC</last_name>
      <phone>206-987-5678</phone>
      <email>klane.white@seattlechildrens.org</email>
    </contact>
    <investigator>
      <last_name>Klane White, MD, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universidade de São Paulo</name>
      <address>
        <city>São Paulo</city>
        <zip>05508-070</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberto Guarniero, MSc, PhD, FSBOT</last_name>
      <email>robertoguarniero@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Roberto Guarniero, MSc, PhD, FSBOT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Calgary</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 4N1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fábio Ferri-de-Barros, MD, FSBOT</last_name>
      <email>ferridb@ucalgary.ca</email>
    </contact>
    <investigator>
      <last_name>Fábio Ferri-de-Barros, MD, FSBOT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>BC Children's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6H 3V4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>IWK Health Centre</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3K 6R8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Hospital for Sick Children</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1X8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andrew Howard, MD, FRCSC</last_name>
      <phone>416-813-6430</phone>
      <email>andrew.howard@sickkids.ca</email>
    </contact>
    <investigator>
      <last_name>Andrew Howard, MD, FRCSC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children`s Hospital Hamburg-Altona</name>
      <address>
        <city>Hamburg</city>
        <zip>22763</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ralf Stuecker, MD</last_name>
      <phone>040 88908382</phone>
      <email>ralf.stuecker@kinderkrankenhaus.net</email>
    </contact>
    <investigator>
      <last_name>Ralf Stuecker, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kinderzentrum Mecklenburg</name>
      <address>
        <city>Schwerin</city>
        <zip>22609</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ludwig Meiss, MD</last_name>
      <email>l.meiss@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Barbara Behnke</last_name>
      <email>Barbara.Behnke@uksh.de</email>
    </contact_backup>
    <investigator>
      <last_name>Ludwig Meiss, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kasturba Medical College (KMC), Manipal</name>
      <address>
        <city>Manipal</city>
        <state>Karnataka</state>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hitesh Shah</last_name>
      <phone>0820- 2922754</phone>
      <email>hiteshshah12@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Benjamin Joseph, MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hitesh Shah</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seoul National University Childrens Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>WonJoon Yoo, MD</last_name>
      <email>yoowj@snu.ac.kr</email>
    </contact>
    <investigator>
      <last_name>WonJoon Yoo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shriners Hospital for Children</name>
      <address>
        <city>Mexico City</city>
        <state>Mexico, DF</state>
        <zip>04600</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pablo Castañeda, MD</last_name>
      <phone>5255 16647064</phone>
      <email>pablocastaneda@me.com</email>
    </contact>
    <investigator>
      <last_name>Pablo Castañeda, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ola Wiig, MD, PhD</last_name>
      <phone>+4795168380</phone>
      <email>ola.wiig@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ola Wiig, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University of Lodz, Poland</name>
      <address>
        <city>Lodz</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marek Synder, MD</last_name>
    </contact>
    <investigator>
      <last_name>Marek Synder, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bristol Royal Hospital for Children</name>
      <address>
        <city>Bristol</city>
        <state>Avon</state>
        <zip>BS2 8BJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simon Thomas</last_name>
      <phone>0117 3428755</phone>
      <email>Simon.Thomas@UHBristol.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Simon Thomas, MA, MBBS, MRCS, FRCS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sanjeev Madan</name>
      <address>
        <city>Sheffield</city>
        <state>South Yorkshire</state>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Southampton</name>
      <address>
        <city>Southampton</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicholas Clarke</last_name>
      <email>prtho@soton.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Nicholas Clarke</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
    <country>Canada</country>
    <country>Germany</country>
    <country>India</country>
    <country>Korea, Republic of</country>
    <country>Mexico</country>
    <country>Norway</country>
    <country>Poland</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.perthesdisease.org</url>
    <description>IPSG Website</description>
  </link>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 2, 2014</study_first_submitted>
  <study_first_submitted_qc>January 15, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 20, 2014</study_first_posted>
  <last_update_submitted>February 8, 2018</last_update_submitted>
  <last_update_submitted_qc>February 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Texas Scottish Rite Hospital for Children</investigator_affiliation>
    <investigator_full_name>Harry Kim, MD</investigator_full_name>
    <investigator_title>Director of Research</investigator_title>
  </responsible_party>
  <keyword>femur head necrosis</keyword>
  <keyword>hip</keyword>
  <keyword>pediatric orthopedics</keyword>
  <keyword>MRI</keyword>
  <keyword>Osteonecrosis</keyword>
  <keyword>Bone diseases</keyword>
  <keyword>Legg Calve Perthes Syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Legg-Calve-Perthes Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Patient enrolled in study will be deidentified (a specific ID will be assigned to participants) in each respective site, Each site will be in charge of entering their respective data in a main database. Data analysis of this collective data will be done mainly through the host site.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

